A. B. Gottlieb, “Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial”, J of Skin, vol. 1, no. 3.1, p. s97, Oct. 2017.